Calcium phosphate cement: in vitro and in vivo studies of the α-tricalcium phosphate-dicalcium phosphate dibasic-tetracalcium phosphate monoxide system

1995 ◽  
Vol 6 (6) ◽  
pp. 340-347 ◽  
Author(s):  
K. Kurashina ◽  
H. Kurita ◽  
M. Hirano ◽  
J. M. A. de Blieck ◽  
C. P. A. T. Klein ◽  
...  
Keyword(s):  
Calcium Phosphate ◽  
Calcium Phosphate Cement ◽  
Tricalcium Phosphate ◽  
Dicalcium Phosphate ◽  
In Vivo Studies ◽  
Tetracalcium Phosphate

scholarly journals Polymeric-Calcium Phosphate Cement Composites-Material Properties:In VitroandIn VivoInvestigations

2010 ◽  
Vol 2010 ◽  
pp. 1-14 ◽  
Author(s):  
Rania M. Khashaba ◽  
Mervet M. Moussa ◽  
Donald J. Mettenburg ◽  
Frederick A. Rueggeberg ◽  
Norman B. Chutkan ◽  
...  
Keyword(s):  
Calcium Phosphate ◽  
Calcium Phosphate Cement ◽  
Setting Time ◽  
Cement Composites ◽  
Tetracalcium Phosphate ◽  
Methyl Vinyl Ether ◽  
Orthopedic Applications ◽  
Hydroxyapatite Cement

New polymeric calcium phosphate cement composites (CPCs) were developed. Cement powder consisting of 60 wt% tetracalcium phosphate, 30 wt% dicalcium phosphate dihydrate, and 10 wt% tricalcium phosphate was combined with either 35% w/w poly methyl vinyl ether maleic acid or polyacrylic acid to obtain CPC-1 and CPC-2. The setting time and compressive and diametral tensile strength of the CPCs were evaluated and compared with that of a commercial hydroxyapatite cement.In vitrocytotoxicity andin vivobiocompatibility of the two CPCs and hydroxyapatite cement were assessed. The setting time of the cements was 5–15 min. CPC-1 and CPC-2 showed significantly higher compressive and diametral strength values compared to hydroxyapatite cement. CPC-1 and CPC-2 were equivalent to Teflon controls after 1 week. CPC-1, CPC-2, and hydroxyapatite cement elicited a moderate to intense inflammatory reaction at 7 days which decreased over time. CPC-1 and CPC-2 show promise for orthopedic applications.

Freeze-Casted Nanostructured Apatite Scaffold Obtained from Low Temperature Biomineralization of Reactive Calcium Phosphates

2013 ◽  
Vol 587 ◽  
pp. 21-26 ◽  
Author(s):  
Saeed Hesaraki
Keyword(s):  
Low Temperature ◽  
Calcium Phosphates ◽  
Aqueous Suspension ◽  
Dicalcium Phosphate ◽  
In Vivo Studies ◽  
Freeze Casting ◽  
Tetracalcium Phosphate ◽  
Freeze Dried

Macroporous nanostructured calcium phosphate scaffold was produced at low temperature using freeze casting technique. Aqueous suspension of tetracalcium phosphate and dicalcium phosphate anhydrous was freeze-casted into cylindrical samples using an automated freeze casting device and subsequently freeze-dried. The sample was stored at 37 °C and 100% relative humidity for 24h, and then kept in simulated body fluid (SBF) for 7 days. The phase composition and microstructure of scaffold was characterized by X-ray diffraction and scanning electronic microscopy, respectively. Cell proliferation and attachment was also studied using Rat calvarium osteoblasts. The results showed a porous structure with total porosity of 75% and pore diameter ranging 50-150 μm and compressive strength of 5 ± 1 Mpa. The scaffolds had been composed of needle-like nanocrystals at the range of 40-100 nm. The XRD and FTIR data confirmed complete conversion of tetracalcium phosphate and dicalcium phosphate reactants into carbonate-substituted apatite phase due to the immersion process without any other impure phases. The results of cell studies revealed well attachment of osteoblasts on the pores and walls of the scaffolds as well as a time dependent proliferation and increased alkaline phosphatase activity. The produced scaffold has the requirements of an osteoinductive material but more in vitro and in vivo studies are required to prove this suggestion.

scholarly journals In Vitro Release of Bioactive Bone Morphogenetic Proteins (GDF5, BB-1, and BMP-2) from a PLGA Fiber-Reinforced, Brushite-Forming Calcium Phosphate Cement

Pharmaceutics ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 455
Author(s):  
Francesca Gunnella ◽  
Elke Kunisch ◽  
Victoria Horbert ◽  
Stefan Maenz ◽  
Jörg Bossert ◽  
...  
Keyword(s):  
Calcium Phosphate ◽  
Cell Lines ◽  
Bone Morphogenetic Proteins ◽  
Calcium Phosphate Cement ◽  
Targeted Delivery ◽  
Calf Serum ◽  
In Vivo Studies ◽  
Alp Activity

Bone regeneration of sheep lumbar osteopenia is promoted by targeted delivery of bone morphogenetic proteins (BMPs) via a biodegradable, brushite-forming calcium-phosphate-cement (CPC) with stabilizing poly(l-lactide-co-glycolide) acid (PLGA) fibers. The present study sought to quantify the release and bioactivity of BMPs from a specific own CPC formulation successfully used in previous in vivo studies. CPC solid bodies with PLGA fibers (0%, 5%, 10%) containing increasing dosages of GDF5, BB-1, and BMP-2 (2 to 1000 µg/mL) were ground and extracted in phosphate-buffered saline (PBS) or pure sheep serum/cell culture medium containing 10% fetal calf serum (FCS; up to 30/31 days). Released BMPs were quantified by ELISA, bioactivity was determined via alkaline phosphatase (ALP) activity after 3-day exposure of different osteogenic cell lines (C2C12; C2C12BRlb with overexpressed BMP-receptor-1b; MCHT-1/26; ATDC-5) and via the influence of the extracts on the expression of osteogenic/chondrogenic genes and proteins in human adipose tissue-derived mesenchymal stem cells (hASCs). There was hardly any BMP release in PBS, whereas in medium + FCS or sheep serum the cumulative release over 30/31 days was 11–34% for GDF5 and 6–17% for BB-1; the release of BMP-2 over 14 days was 25.7%. Addition of 10% PLGA fibers significantly augmented the 14-day release of GDF5 and BMP-2 (to 22.6% and 43.7%, respectively), but not of BB-1 (13.2%). All BMPs proved to be bioactive, as demonstrated by increased ALP activity in several cell lines, with partial enhancement by 10% PLGA fibers, and by a specific, early regulation of osteogenic/chondrogenic genes and proteins in hASCs. Between 10% and 45% of bioactive BMPs were released in vitro from CPC + PLGA fibers over a time period of 14 days, providing a basis for estimating and tailoring therapeutically effective doses for experimental and human in vivo studies.

Electrospun Nanofibrous P(DLLA–CL) Balloons as Calcium Phosphate Cement Filled Containers for Bone Repair: in Vitro and in Vivo Studies

2015 ◽  
Vol 7 (33) ◽  
pp. 18540-18552 ◽  
Author(s):  
Xunwei Liu ◽  
Daixu Wei ◽  
Jian Zhong ◽  
Mengjia Ma ◽  
Juan Zhou ◽  
...  
Keyword(s):  
Calcium Phosphate ◽  
Calcium Phosphate Cement ◽  
Bone Repair ◽  
In Vivo Studies

scholarly journals A Review on the Enhancement of Calcium Phosphate Cement with Biological Materials in Bone Defect Healing

Polymers ◽  
2021 ◽  
Vol 13 (18) ◽  
pp. 3075
Author(s):  
Sok Kuan Wong ◽  
Yew Hoong Wong ◽  
Kok-Yong Chin ◽  
Soelaiman Ima-Nirwana
Keyword(s):  
Calcium Phosphate ◽  
Calcium Phosphate Cement ◽  
Research Effort ◽  
Biological Materials ◽  
Biological Properties ◽  
Comprehensive Overview ◽  
Bone Defect Healing ◽  
Living Organisms

Calcium phosphate cement (CPC) is a promising material used in the treatment of bone defects due to its profitable features of self-setting capability, osteoconductivity, injectability, mouldability, and biocompatibility. However, the major limitations of CPC, such as the brittleness, lack of osteogenic property, and poor washout resistance, remain to be resolved. Thus, significant research effort has been committed to modify and reinforce CPC. The mixture of CPC with various biological materials, defined as the materials produced by living organisms, have been fabricated by researchers and their characteristics have been investigated in vitro and in vivo. This present review aimed to provide a comprehensive overview enabling the readers to compare the physical, mechanical, and biological properties of CPC upon the incorporation of different biological materials. By mixing the bone-related transcription factors, proteins, and/or polysaccharides with CPC, researchers have demonstrated that these combinations not only resolved the lack of mechanical strength and osteogenic effects of CPC but also further improve its own functional properties. However, exceptions were seen in CPC incorporated with certain proteins (such as elastin-like polypeptide and calcitonin gene-related peptide) as well as blood components. In conclusion, the addition of biological materials potentially improves CPC features, which vary depending on the types of materials embedded into it. The significant enhancement of CPC seen in vitro and in vivo requires further verification in human trials for its clinical application.

Sign in / Sign up

Export Citation Format

Share Document